Randomized Open-Label Trial to Assess the Impact of Dosage Timing of Omeprazole/Sodium Bicarbonate (Zegerid 40 mg) on Healing of Severe Reflux Esophagitis: Preliminary Results

Autor:	Joseph A. Murray, Kaiser G. Lim, Judith McElhiney, Steven C. Adamson, Rayna Grothe, Adil A. Abdalla, Matthew R. Lohse, Jeffrey A. Alexander, Kee Wook Jung, Felicity Enders, Tushar S. Dabade, Andrew J. Majka, John Patt, Michael D. Crowell, Vikneswaran Namasivayam, Mary Fredericksen, Nancy N. Diehl, Angela E. O'Neil, Debra M. Geno, Dawn L. Francis, Virender K. Sharma, Amindra S. Arora, Ramona S. DeJesus, Yvonne Romero, Ganapathy A. Prasad
Rok vydání:	2009
Předmět:	medicine.medical_specialty Hepatology business.industry Internal medicine Gastroenterology medicine Open label Reflux esophagitis business OMEPRAZOLE/SODIUM BICARBONATE
Zdroj:	American Journal of Gastroenterology. 104:S8
ISSN:	0002-9270
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::69b0927083cad5ea70d5f6ba22fbbdf6 https://doi.org/10.14309/00000434-200910003-00020 Zobrazit plný text záznamu